Mr Peter J Isely, LCSW in Wauwatosa, WI - Social Worker

Mr Peter J Isely, LCSW is a Social Worker - Clinical based in Wauwatosa, Wisconsin. Mr Peter J Isely is licensed to practice in Wisconsin (license number 2997-123) and his current practice location is 10045 W Lisbon Ave, Wauwatosa, Wisconsin. He can be reached at his office (for appointments etc.) via phone at (414) 429-7259.

NPI number for Mr Peter J Isely is 1053706226 and his current mailing address is 10045 W Lisbon Ave, Wauwatosa, Wisconsin. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1053706226.

Contact Information

	Mr Peter J Isely, LCSW
	10045 W Lisbon Ave, Wauwatosa, WI 53222-2446
	(414) 429-7259
	(414) 393-1460

Healthcare Provider's Profile

Full Name	Mr Peter J Isely
Gender	Male
Speciality	Social Worker - Clinical
Location	10045 W Lisbon Ave, Wauwatosa, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1053706226
Provider Enumeration Date: 04/03/2015
Last Update Date: 04/03/2015

Medical Identifiers

Medical identifiers for Mr Peter J Isely such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053706226	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	2997-123 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Peter J Isely is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Peter J Isely, LCSW 10045 W Lisbon Ave, Wauwatosa, WI 53222-2446 Ph: (414) 429-7259	Mr Peter J Isely, LCSW 10045 W Lisbon Ave, Wauwatosa, WI 53222-2446 Ph: (414) 429-7259

News Archive

Phase Forward Central Coding application achieves UMC's new certification

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced its Central Coding™ application has become the first product to achieve certification by the Uppsala Monitoring Center (UMC). Launched today ("Uppsala Monitoring Centre Launches Software Certification Program for WHO Drug Dictionary Enhanced"), UMC's new certification is designed to help software developers quickly and easily integrate the WHO Drug Dictionary Enhanced.

AcelRx commences third ARX-01 Phase 3 study in post-operative pain

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced dosing of the first patient in the third of three planned Phase 3 studies for ARX-01, the Sufentanil NanoTab PCA System, its novel sublingual patient-controlled analgesia (PCA) system.

Findings may help develop new antiviral drugs for influenza

Investigators at Burnham Institute for Medical Research (Burnham), Mount Sinai School of Medicine (Mount Sinai), the Salk Institute for Biological Studies (Salk) and the Genomics Institute of the Novartis Research Foundation (GNF) have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1.

World-first trial of third dose COVID-19 booster vaccine shows improved protection in transplant patients

Scientists with the Ajmera Transplant Centre at UHN have conducted a first-in-the-world randomized placebo-controlled trial of third dose COVID-19 booster vaccine for transplant patients that shows substantially improved protection.

Nutraceuticals could play an important role in preventing heart disease

Older adults who take a novel antioxidant that specifically targets cellular powerhouses, or mitochondria, see age-related vascular changes reverse by the equivalent of 15 to 20 years within six weeks, according to new University of Colorado Boulder research.

Social Worker in Wauwatosa, WI

Danielle S Carlson, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 10702 W Burleigh St, Wauwatosa, WI 53222 Phone: 414-777-0740 Fax: 414-777-0749
Mrs. Jill Marie Goldsworthy, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 10045 W Lisbon Ave, Suite 221, Wauwatosa, WI 53222 Phone: 414-358-7146
Lisa Wentworth-rohr, MA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11121 W North Ave, Suite 220, Wauwatosa, WI 53226 Phone: 262-780-9788 Fax: 414-443-2719
Christine S Schultz, Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 1220 Dewey Ave, Wauwatosa, WI 53213 Phone: 414-454-6707
Lisa Derosa Hill, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10045 W Lisbon Ave, Wauwatosa, WI 53222 Phone: 414-358-7144 Fax: 414-358-7158
Mr. Michael John Schuette, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1220 Dewey Ave, Wauwatosa, WI 53213 Phone: 414-773-4339 Fax: 414-454-6747

Mr Peter J Isely, LCSW - Clinical Social Worker in Wauwatosa, WI